Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Non-Coding mRNA: Merck & Co' Novel Drug Target For Antibacterials And Possibly Human Disease

This article was originally published in Scrip

Executive Summary

Merck & Co researchers have found a small-molecule modulator of non-coding elements in bacterial mRNA that points the way to the development of new antibacterials with a totally new mode of action, and possibly novel medicines for human disease too.



Related Companies